Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_provenance.
- NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_assertion description "[Inhibitors of the tyrosine kinase receptors, such as IGF-1R, c-kit, PDGFR, VEGFR, or the mTOR signaling pathway, proteasome, angiogenesis, and stress response proteins are under clinical evaluation against sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_provenance.
- NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_assertion evidence source_evidence_literature NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_provenance.
- NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_assertion SIO_000772 19013896 NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_provenance.
- NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_assertion wasDerivedFrom befree-20140225 NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_provenance.
- NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_assertion wasGeneratedBy ECO_0000203 NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_provenance.
- befree-20140225 importedOn "2014-02-25" NP717056.RAeDsydUSx7qIH4DqNuXI8epZB8UYJznAu9qIIKKQ9Oio130_provenance.